Maxim Group Raises scPharmaceuticals (NASDAQ:SCPH) Price Target to $20.00
ScPharmaceuticals (NASDAQ:SCPH – Get Rating) had its price objective lifted by Maxim Group from $13.00 to $20.00 in a research report released on Thursday morning, The Fly reports. Several other research firms have also weighed in on SCPH. HC Wainwright reissued a buy rating and set a $18.00 price objective on shares of scPharmaceuticals in […]